ThesisRisk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
ThesisRisk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
ThesisA correlative study between early atherosclerosis and disease activity in systemic lupus erythematosus patients
ThesisA correlative study between early atherosclerosis and disease activity in systemic lupus erythematosus patients
ThesisEvaluation of coronary artery disease in systemic lupus erythematosus and scleroderma : Correlation with pulmonary hpertension and disease activity
ThesisEvaluation of coronary artery disease in systemic lupus erythematosus and scleroderma : Correlation with pulmonary hpertension and disease activity
ThesisEndothelial dysfunction in systemic lupus erythematosus assessed by flow mediated dilatation of brachial artery
ThesisEndothelial dysfunction in systemic lupus erythematosus assessed by flow mediated dilatation of brachial artery
ThesisLipid profile in systemic lupus erythematosus patients and its correlation with diseaseactivity parameters
ThesisLipid profile in systemic lupus erythematosus patients and its correlation with diseaseactivity parameters
ThesisOrgan damage in systemic lupus erythematosus : Its correlation with various clinical and laboratory data
ThesisOrgan damage in systemic lupus erythematosus : Its correlation with various clinical and laboratory data
ThesisThe role of lipocalin-2 as a biomarker in the renal disease activity in patients with systemic lupus erythematosus
ThesisThe role of lipocalin-2 as a biomarker in the renal disease activity in patients with systemic lupus erythematosus